Volume 20, Number 7—July 2014
Research
Norovirus Epidemiology in Community and Health Care Settings and Association with Patient Age, Denmark
Table 2
Variable | All patients with an assigned genotype, n = 1,952 |
Sensitivity analysis 1, n = 1,299 patients |
Sensitivity analysis 2, n = 1,566 patients |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Total no. (%)† | No. (%) positive for GII.4‡ | OR | 95% CI | OR | 95% CI | OR | 95% CI | |||
Community settings | ||||||||||
Age, y | ||||||||||
<3 | 558 (63) | 291 (52) | 0.60 | 0.39–0.91 | 0.46 | 0.25–0.86 | 0.63 | 0.40–1.00 | ||
3–19 | 80 (9) | 21 (26) | 0.19 | 0.10–0.37 | 0.09 | 0.03–0.24 | 0.22 | 0.11–0.43 | ||
20–39 | 114 (13) | 73 (64) | Ref | NA | Ref | NA | Ref | NA | ||
40–59 | 66 (7) | 43 (65) | 1.03 | 0.54–1.95 | 0.86 | 0.30–2.42 | 1.07 | 0.55–2.08 | ||
≥60 | 64 (7) | 53 (83) | 2.71 | 1.27–5.78 | 2.23 | 0.73–6.88 | 2.86 | 1.32–6.19 | ||
Health care settings |
||||||||||
Age, y | ||||||||||
<3 | 25 (2) | 13 (52) | 0.46 | 0.16–1.29 | 0.50 | 0.13–1.98 | 0.75 | 0.25–2.22 | ||
3–19 | 12 (1) | 6 (50) | 0.41 | 0.11–1.52 | 0.23 | 0.04–1.19 | 0.58 | 0.14–2.41 | ||
20–39 | 44 (4) | 31 (71) | 1 (Ref) | NA | 1 (Ref) | NA | 1 (Ref) | NA | ||
40–59 | 119 (11) | 107 (90) | 3.73 | 1.54–9.05 | 3.42 | 1.20–9.72 | 4.59 | 1.75–12.09 | ||
≥60 | 870 (81) | 828 (95) | 8.39 | 4.07–17.29 | 8.37 | 3.55–19.78 | 9.62 | 4.38–21.12 | ||
Sex | ||||||||||
M | 965 (49) | 716 (74) | 1.23 | 0.96–1.56 | 1.26 | 0.92–1.74 | 1.22 | 0.95–1.58 | ||
F | 987 (51) | 750 (76) | Ref |
NA |
Ref |
NA |
Ref |
NA |
||
Estimate |
SE |
Estimate |
SE |
Estimate |
SE |
|||||
Variation between clusters§ | NA | NA | 0.053 | 0.089 | 0.062 | 0.101 | NA | NA | ||
Intraclass correlation coefficient | NA | NA | 2.6% | NA | 1.95% | NA | NA | NA | ||
Dispersion parameter | NA | NA | 0.99 | NA | 0.99 | NA | 1.01 | NA |
*Sensitivity analysis 1 was a multilevel logistic regression model that included only wards and clinics with ≥5 patients. Sensitivity analysis 2 was a logistic regression model (without random effect) that included only the first patient per month within each ward and clinic. GII, genogroup II; OR, odds ratio; Ref, referent; NA, not applicable. An OR>1 indicates an increased risk for norovirus GII.4 infection compared with patients 20–39 y of age.
†Proportions for community settings do not add up to 100% because of rounding.
‡Proportion of patients infected with norovirus GII.P4 or GII.4 in each age or sex group.
§Estimated to be 1.12 (SE 0.18) in the random intercept-only model (i.e., without the effect of age, sex, and setting).
Page created: June 17, 2014
Page updated: June 17, 2014
Page reviewed: June 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.